Rina Aharoni Selected Research

Rina Aharoni Research Topics

Disease

22	Multiple Sclerosis 01/2022 - 05/2002
18	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 12/2021 - 05/2002
6	Colitis 05/2011 - 10/2004
5	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 05/2011 - 02/2005
4	Inflammation (Inflammations) 12/2019 - 11/2008
4	Demyelinating Diseases (Demyelinating Disease) 12/2019 - 08/2008
3	Pathologic Processes 03/2019 - 11/2003
3	Disease Progression 11/2014 - 08/2010
2	Relapsing-Remitting Multiple Sclerosis 03/2019 - 12/2004
2	Neoplasms (Cancer) 01/2014 - 09/2010
1	Cognitive Dysfunction 11/2019
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 10/2015
1	Encephalomyelitis (Myeloencephalitis) 10/2014
1	Infections 01/2014
1	Gliosis 10/2012
1	Chronic Disease (Chronic Diseases) 10/2012
1	Central Nervous System Infections (Central Nervous System Infection) 09/2010
1	Neurodegenerative Diseases (Neurodegenerative Disease) 07/2009
1	Nervous System Diseases (Neurological Disorders) 12/2007
1	Body Weight (Weight, Body) 02/2005
1	Crohn Disease (Crohn's Disease) 02/2005
1	Weight Loss (Weight Reduction) 10/2004

Drug/Important Bio-Agent (IBA)

23	Glatiramer Acetate (Copaxone)FDA Link 12/2021 - 05/2002
13	Pharmaceutical PreparationsIBA 03/2019 - 11/2003
7	CytokinesIBA 03/2019 - 09/2003
6	Therapeutic UsesIBA 01/2020 - 02/2005
5	Immunologic Factors (Immunomodulators)IBA 05/2011 - 01/2005
4	Peptides (Polypeptides)IBA 01/2022 - 01/2016
3	Myelin-Oligodendrocyte GlycoproteinIBA 12/2021 - 01/2016
3	AntibodiesIBA 01/2017 - 01/2016
3	Sulfonic AcidsIBA 10/2007 - 10/2004
2	tuftsin-phosphorylcholineIBA 02/2020 - 12/2019
2	Brain-Derived Neurotrophic Factor (BDNF)IBA 10/2012 - 12/2005
2	Dextrans (Dextran)FDA Link 05/2011 - 11/2008
2	Transforming Growth Factor beta (TGF-beta)IBA 11/2008 - 10/2007
2	Dextran SulfateIBA 10/2007 - 07/2006
2	Nerve Growth Factors (Neurotrophins)IBA 12/2005 - 11/2003
1	Myelin Basic ProteinIBA 01/2022
1	Immunoglobulin M (IgM)IBA 01/2022
1	Glutamic Acid (Glutamate)FDA Link 12/2021
1	Neuroprotective AgentsIBA 12/2021
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2020
1	Choline (Choline Chloride)IBA 12/2016
1	LipidsIBA 01/2016
1	AntigensIBA 01/2016
1	EpitopesIBA 01/2016
1	PerforinIBA 10/2015
1	Interferon Type IIBA 10/2014
1	Biomarkers (Surrogate Marker)IBA 10/2014
1	Proteins (Proteins, Gene)FDA Link 02/2013
1	Glycoproteins (Glycoprotein)IBA 02/2013
1	laquinimodIBA 10/2012
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 05/2011
1	Syndecan-1 (Syndecan 1)IBA 05/2011
1	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 05/2011
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 11/2008
1	Transcription Factors (Transcription Factor)IBA 11/2008
1	Messenger RNA (mRNA)IBA 11/2008
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 09/2003

Therapy/Procedure

5	Therapeutics 03/2019 - 07/2009
4	Immunomodulation 04/2014 - 11/2008
1	Bone Marrow Transplantation (Transplantation, Bone Marrow) 10/2015
1	Transplantation 01/2014
1	Injections 12/2005
1	Rectal Administration 02/2005
1	Oral Administration 12/2004
1	Mucosal Administration 05/2002